RGEN
REPLIGEN CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$176.89
−0.73%Forward multiples
Based on analyst estimates
- P/E forward
- 78.26x
- P/E 2026E
- 86.60x
- P/E 2027E
- 67.74x
- P/E 2028E
- 51.71x
- P/S forward
- 11.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- 239.04x
- PEG TTM
- 1.17x
- Price / book
- 4.73x
- Price / sales
- 12.72x
- Price / cash flow
- 74.02x
Enterprise value
- Enterprise value
- $9.9B
- EV / sales
- 12.56x
- EV / EBITDA
- 80.96x
- EV / EBIT
- 151.05x
- Market cap
- $10.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026